Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,150.00
Bid: 3,140.00
Ask: 3,142.00
Change: -10.00 (-0.32%)
Spread: 2.00 (0.064%)
Open: 3,156.00
High: 3,180.00
Low: 3,086.00
Prev. Close: 3,160.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio update and Capital Markets Seminar

23 Sep 2020 07:00

RNS Number : 7923Z
3i Group PLC
23 September 2020
 

 

Press release

23 September 2020

 

3i Group plc

Update on the portfolio and Capital Markets Seminar

 

3i Group plc ("3i" or "the Group") will be holding a Capital Markets Seminar via webcast today, involving presentations on our approach to ESG and responsible investment, as well as on Evernex and SaniSure, two of our recent Private Equity Investments. In addition, Simon Borrows, our Chief Executive, will provide an update on the portfolio, the key elements of which are outlined below. The seminar will start at 14.00 and the joining details are provided at the end of this press release. The presentation materials and a recording of the webcast will also be made available on our website.

We have now completed our September semi-annual portfolio company reviews for Private Equity, Infrastructure and Scandlines, which have reinforced our belief in the resilience and strength of earnings performance in the significant majority of our investments. The automotive sector remains challenged, and public health policy has prolonged the uncertainty for the travel sector. However, we continue to see strong momentum in portfolio companies exposed to medical technology and personal care products and very good recovery in our retail businesses, particularly in online, and of course in Action.

Action's impressive performance has continued with sales, EBITDA and cash generation above expectations for P7 (July), P8 (August) and P9 (September) to date. YTD sales at over €3.7 billion have now recovered to be approximately 8% ahead of last year with strong trading continuing across all geographies. We expect LTM EBITDA to the end of P9 to be approximately €575 million compared to €506 million at September last year and €491 million at the end of P4 this year. Cash generation has continued to be strong with a current cash balance of over €625 million after a €51 million repayment of the RCF. Action has now opened 88 stores in 2020 including its first five stores in the Czech Republic. Initial trading in the Czech Republic has been significantly ahead of expectations.

A live webcast of the seminar will be available at 14.00. To register for the webcast, please visit www.3i.com/investor-relations/capital-markets-presentations/2020.

 

- Ends-

 

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

 

 

Notes to editors:

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America.

 

For further information, please visit: www.3i.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDCXSDDGGD
Date   Source Headline
28th Feb 20143:32 pmRNSDirector/PDMR Shareholding
12th Feb 201412:01 pmRNSNew leadership of Infrastructure business
7th Feb 20142:05 pmRNSDirector/PDMR Shareholding
31st Jan 20143:48 pmRNSTotal Voting Rights
31st Jan 20143:45 pmRNSDirector/PDMR Shareholding
30th Jan 20147:00 amRNSInterim Management Statement
13th Jan 20142:43 pmRNSDirector/PDMR Shareholding
7th Jan 20143:22 pmRNSPortfolio Update
31st Dec 201312:21 pmRNSTotal Voting Rights
31st Dec 201312:18 pmRNSDirector/PDMR Shareholding
19th Dec 20134:42 pmRNSHolding(s) in Company
19th Dec 20134:36 pmRNSDirector/PDMR Shareholding
12th Dec 201311:34 amRNSHolding(s) in Company
9th Dec 201311:23 amRNSHolding(s) in Company
9th Dec 201311:08 amRNSBlocklisting Interim Review
5th Dec 201310:26 amRNSHolding(s) in Company
29th Nov 20133:01 pmRNSDirector/PDMR Shareholding
29th Nov 20132:53 pmRNSTotal Voting Rights
29th Nov 20132:46 pmRNSDirector/PDMR Shareholding
27th Nov 201310:28 amRNSHolding(s) in Company
26th Nov 20134:21 pmRNSDirector/PDMR Shareholding
26th Nov 20134:16 pmRNSDirector/PDMR Shareholding
26th Nov 20133:05 pmRNSHolding(s) in Company
18th Nov 201311:15 amRNSHolding(s) in Company
15th Nov 201310:31 amRNSDirector/PDMR Shareholding
14th Nov 20133:19 pmRNSHolding(s) in Company
14th Nov 20131:34 pmRNSDoc re. 2013 Half Yearly Report
14th Nov 20137:00 amRNSHalf Yearly Report
12th Nov 20139:13 amRNSDirectorate Change
11th Nov 20137:00 amRNSCompletion of acquisition
6th Nov 201311:02 amRNSHolding(s) in Company
5th Nov 20134:02 pmRNSHolding(s) in Company
31st Oct 20131:59 pmRNSTotal Voting Rights
31st Oct 20131:53 pmRNSDirector/PDMR Shareholding
23rd Oct 201311:28 amRNSHolding(s) in Company
7th Oct 20133:12 pmRNSHolding(s) in Company
3rd Oct 201311:55 amRNSPortfolio Update
2nd Oct 201311:21 amRNSHolding(s) in Company
30th Sep 20133:27 pmRNSTotal Voting Rights
30th Sep 20133:18 pmRNSDirector/PDMR Shareholding
24th Sep 20138:00 amRNSPrivate Equity Capital Markets Seminar
19th Sep 201310:40 amRNSHolding(s) in Company
16th Sep 201312:13 pmRNSHolding(s) in Company
13th Sep 201310:37 amRNSHolding(s) in Company
6th Sep 20134:54 pmRNSDirector/PDMR Shareholding
4th Sep 20132:11 pmRNSHolding(s) in Company
30th Aug 20134:46 pmRNSTotal Voting Rights
30th Aug 20134:45 pmRNSDirector/PDMR Shareholding
7th Aug 201311:06 amRNSDirector/PDMR Shareholding
31st Jul 20134:38 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.